IRIS
REFINI, ROSA METELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.106
EU - Europa 5.816
AS - Asia 2.285
SA - Sud America 362
AF - Africa 54
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 14.634
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.009
IT - Italia 1.352
RU - Federazione Russa 1.151
GB - Regno Unito 1.106
CN - Cina 828
SG - Singapore 767
IE - Irlanda 723
SE - Svezia 398
BR - Brasile 313
UA - Ucraina 274
DE - Germania 264
HK - Hong Kong 208
FR - Francia 193
FI - Finlandia 138
VN - Vietnam 110
KR - Corea 74
TR - Turchia 68
ES - Italia 61
IN - India 59
CA - Canada 50
BD - Bangladesh 36
MX - Messico 33
BE - Belgio 30
CZ - Repubblica Ceca 27
PL - Polonia 25
JP - Giappone 21
ZA - Sudafrica 20
IQ - Iraq 18
PK - Pakistan 16
AR - Argentina 13
AT - Austria 13
EC - Ecuador 13
CI - Costa d'Avorio 12
IR - Iran 12
MA - Marocco 12
SA - Arabia Saudita 10
ID - Indonesia 9
LT - Lituania 9
PT - Portogallo 8
AE - Emirati Arabi Uniti 7
NL - Olanda 7
AU - Australia 6
AZ - Azerbaigian 5
JO - Giordania 5
KZ - Kazakistan 5
PE - Perù 5
UY - Uruguay 5
UZ - Uzbekistan 5
CH - Svizzera 4
CL - Cile 4
DK - Danimarca 4
HU - Ungheria 4
IL - Israele 4
JM - Giamaica 4
LB - Libano 4
PH - Filippine 4
RO - Romania 4
VE - Venezuela 4
AL - Albania 3
BG - Bulgaria 3
DZ - Algeria 3
EG - Egitto 3
EU - Europa 3
GR - Grecia 3
IS - Islanda 3
TT - Trinidad e Tobago 3
CO - Colombia 2
CR - Costa Rica 2
HN - Honduras 2
KG - Kirghizistan 2
LV - Lettonia 2
NO - Norvegia 2
NP - Nepal 2
AQ - Antartide 1
BH - Bahrain 1
BO - Bolivia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GH - Ghana 1
GY - Guiana 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PY - Paraguay 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 14.634
Salva come PNG Salva come JPEG
Città #
Southend 989
Dallas 721
Dublin 715
Fairfield 675
Singapore 496
Ashburn 468
Chandler 401
Santa Clara 333
Moscow 327
Woodbridge 302
Seattle 283
Beijing 279
Houston 257
Siena 237
Wilmington 232
Jacksonville 225
Cambridge 213
Hong Kong 201
Ann Arbor 155
Princeton 119
New York 110
Dearborn 96
Hefei 79
Los Angeles 78
Seoul 73
Helsinki 72
Munich 70
Lastra a Signa 68
Nanjing 61
Boardman 54
Milan 54
Florence 52
Gavirate 48
San Mateo 45
Izmir 44
Málaga 44
The Dalles 42
Shanghai 38
Buffalo 36
San Diego 35
São Paulo 35
Nanchang 33
Dong Ket 32
Catania 31
Rome 29
Ho Chi Minh City 28
London 26
Turku 24
Fremont 23
Changsha 22
Warsaw 22
Tokyo 20
Brussels 18
Columbus 18
Council Bluffs 18
Chicago 17
Hebei 17
Johannesburg 17
Montreal 17
Chennai 16
Düsseldorf 16
Guangzhou 16
Redondo Beach 16
Hanoi 15
Brno 14
Brooklyn 14
Poplar 14
Shenyang 14
Stockholm 14
Atlanta 13
Boston 13
Kunming 13
San Francisco 13
Abidjan 12
Hangzhou 12
Menlo Park 12
Norwalk 12
Frankfurt am Main 11
Lahore 11
Mexico City 11
Olomouc 11
Prato 11
Toronto 11
Bengaluru 10
Jiaxing 10
Manchester 10
Phoenix 10
Rio de Janeiro 10
Tianjin 10
Trieste 10
Washington 10
Zhengzhou 10
Denver 9
Dhaka 9
Lancaster 9
Montecatini Terme 9
Ningbo 9
Orem 9
Arezzo 8
Baghdad 8
Totale 9.749
Salva come PNG Salva come JPEG
Nome #
La chitotriosidasi: un sensibile biomarker di sarcoidosi 1.025
Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis 319
Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis 309
A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls 306
Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3ε as potential biomarkers 282
Exhaled nitric oxide in interstitial lung diseases 252
Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease 252
Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis 249
Idiopathic pulmonary fibrosis a rare disease with severe bone fragility 247
Familial pulmonary fibrosis: Clinical and radiological characteristics and progression analysis in different high resolution-CT patterns 240
The effect of cigarette smoking on bronchoalveolar lavage protein profiles from patients with different interstitial lung diseases 239
Diagnosis of idiopathic pulmonary fibrosis by virtual means using “IPFdatabase”- a new software 236
Different effects of inhaled aspirinlike drugs on allergen-induced early and late asthmatic responses 235
Role of BNP and echo measurement for pulmonary hypertension recognition in patients with interstitial lung disease: An algorithm application model 234
Posttransplant solid organ malignancies in lung transplant recipients: A single-center experience and review of the literature 233
Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience 231
Pulmonary hypertension in idiopathic pulmonary fibrosis: prevalence and clinical progress 225
Omalizumab treatment in Samter's triad: case series and review of the literature 225
Calgranulin B (S100A9/MRP14): a Key molecule in idiopathic pulmonary fibrosis? 218
Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma 218
Prognostic bioindicators in severe COVID-19 patients 218
Exhaled carbon monoxide in sarcoidosis 217
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 215
Adaptive immune system in pulmonary sarcoidosis - comparison of peripheral and alveolar biomarkers 214
Could NSAIDs have a role as antiasthmatic agents? 212
Pirfenidone therapy for familial pulmonary fibrosis: a real-life study. 209
NK and NKT-like cells in granulomatous and fibrotic lung diseases 203
A functional proteomics approach to the comprehension of sarcoidosis 201
Serum KL-6 concentrations as a novel biomarker of severe COVID-19 201
Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium 196
Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin 195
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 193
Postoperative acute kidney injury in lung transplant recipients 192
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 191
Serum analysis of coagulation factors in IPF and NSIP 189
Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial 188
Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions 187
Acute exacerbation of idiopathic pulmonary fibrosis after inhalation of a water repellent 186
Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting 181
Inhaled loop diuretics as potential new anti-asthmatic drugs 179
Proteomic investigation of pulmonary sarcoidosis 179
Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female 175
Helicobacter pylori Infection Does Not Impact on Lung Transplant Outcome 173
Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis 173
Steroid-sparing effect of inhaled lysine acetylsalicylate and furosemide in high-dose beclomethasone-dependent asthma 171
IPF mortality in waiting list for lung transplantation 171
The Role of Urinary Calcium and Chitotriosidase in a Cohort of Chronic Sarcoidosis Patients 168
Chitotriosidase: a sensitive biomarker of sarcoidosis 162
Mortalità in lista per trapianto di polmone in pazienti affetti da fibrosi polmonare idiopatica 162
P172 Pulmonary Hypertension In Ipf: Utility Of Hrct 158
Familial pulmonary fibrosis: Clinical-functional and radiological features 155
New concepts in the pathogenesis of sarcoidosis 155
Immunologic responses to antifibrotic treatment in IPF patients 153
Time-limited protective effect of inhaled frusemide against aspirin-induced bronchoconstriction in aspirin-sensitive asthmatics 151
Helicobacter pylori seroprevalence in patients with idiopathic pulmonary fibrosis 149
Protective activity of inhaled nonsteroidal antiinflammatory drugs on bronchial responsiveness to ultrasonically nebulized water 148
Chitotriosidase analysis in bronchoalveolar lavage of patients with sarcoidosis. 143
null 143
Valutazione dell'ossido nitrico nell'esalato delle polmoniti interstiziali idiopatiche 134
Utility of spiral CAT scan in the follow-up of patients with pulmonary Largerhans cell histiocytosis 133
Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction 127
Hypercalciuria in Sarcoidosis: A Specific Biomarker With Clinical Utility 127
Potentiation of the antireactive, antiasthmatic effect of inhaled furosemide by inhaled lysine acetylsalicylate 125
Exhaled nitric oxide and carbon monoxide in lung transplanted patients 122
Exhaled carbon monoxide in sarcoidosis 122
Exploring the interaction between fractional exhaled nitric oxide and biologic treatment in severe asthma: a systematic review 122
null 121
Immune checkpoint analysis of T-cell responses to pp65 and IE-1 antigens in end-stage lung diseases 119
The effectiveness of nintedanib in patients with idiopathic pulmonary fibrosis, familial pulmonary fibrosis and progressive fibrosing interstitial lung diseases: a real-world study 107
null 106
Calgranulin B and KL-6 in Bronchoalveolar Lavage of Patients with IPF and NSIP 96
Nintedanib in Idiopathic Pulmonary Fibrosis: a single-centre real-life experience 90
Calgranulin B/S100A9 and KL-6 in bronchoalveolar lavage of patients with IPF and NSIP 81
Human chitotriosidase analysis: a reliable biomarker of sarcoidosis severity 81
Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis 69
Erratum: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis (Respiratory Research (2020) 21 (6) DOI: 10.1186/s12931-019-1263-z) 67
Real-life comparison between pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis 66
null 63
Esperienza in real-life della terapia con Pirfenidone in pazienti affetti da IPF. 37
Serum concentrations of KL-6 in patients with IPF and lung cancer and serial measurements of KL-6 in IPF patients treated with antifibrotic therapy 29
Esperienza in real-life della terapia con Pirfenidone in pazienti affetti da IPF. 29
The value of urinary calcium as biomarker in chronic sarcoidosis 27
Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases 23
Totale 14.854
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.655
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.655
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.001 0 0 0 0 0 194 113 206 116 133 132 107
2021/20221.055 72 133 79 93 54 30 49 43 35 108 150 209
2022/20231.358 87 140 163 169 136 245 50 108 140 58 38 24
2023/20241.218 39 21 105 54 59 311 407 36 8 39 21 118
2024/20252.181 135 100 249 78 301 145 109 103 147 104 240 470
2025/20263.504 381 616 605 675 1.159 68 0 0 0 0 0 0
Totale 14.854